HK1002729A1 - 22-oxacholecalciferol derivative and production thereof - Google Patents

22-oxacholecalciferol derivative and production thereof

Info

Publication number
HK1002729A1
HK1002729A1 HK98101901A HK98101901A HK1002729A1 HK 1002729 A1 HK1002729 A1 HK 1002729A1 HK 98101901 A HK98101901 A HK 98101901A HK 98101901 A HK98101901 A HK 98101901A HK 1002729 A1 HK1002729 A1 HK 1002729A1
Authority
HK
Hong Kong
Prior art keywords
production
oxacholecalciferol
same
oxacholecalciferol derivative
derivative
Prior art date
Application number
HK98101901A
Other languages
English (en)
Inventor
Masahiro Kato
Tetsuhiro Mikami
Kiyoshige Ochi
Hiroyoshi Watanabe
Noboru Kubodera
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of HK1002729A1 publication Critical patent/HK1002729A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
HK98101901A 1991-12-18 1998-03-09 22-oxacholecalciferol derivative and production thereof HK1002729A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP36105191 1991-12-18
PCT/JP1992/001662 WO1993012083A1 (en) 1991-12-18 1992-12-18 22-oxacholecalciferol derivative and production thereof

Publications (1)

Publication Number Publication Date
HK1002729A1 true HK1002729A1 (en) 1998-09-11

Family

ID=18471985

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98101901A HK1002729A1 (en) 1991-12-18 1998-03-09 22-oxacholecalciferol derivative and production thereof

Country Status (13)

Country Link
US (1) US5436401A (xx)
EP (1) EP0619304B1 (xx)
JP (1) JP3493037B2 (xx)
KR (1) KR100247214B1 (xx)
AT (1) ATE157966T1 (xx)
DE (1) DE69222183T2 (xx)
DK (1) DK0619304T3 (xx)
ES (1) ES2107650T3 (xx)
GR (1) GR3025468T3 (xx)
HK (1) HK1002729A1 (xx)
SG (1) SG78265A1 (xx)
TW (1) TW222621B (xx)
WO (1) WO1993012083A1 (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3563310D1 (en) * 1985-07-30 1988-07-21 Salzgitter Ind Method and device for the preparation of suspensions with constant indications from basic materials with variable properties
US6103709A (en) * 1993-12-23 2000-08-15 The Regents Of The University Of California Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases
US6121469A (en) * 1993-12-23 2000-09-19 The Regents Of The University Of California Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs
DK0764443T3 (da) * 1994-04-19 2002-10-07 Chugai Pharmaceutical Co Ltd Midler tl behandling af med tumorer forbundet kakeksi
GB9607034D0 (en) * 1996-04-03 1996-06-05 Leo Pharm Prod Ltd Chemical compounds
EP0931047A1 (en) * 1996-09-03 1999-07-28 The Trustees of Columbia University in the City of New York Intermediates for the synthesis of vitamin d and steroid derivatives and processes for preparation thereof
GB9804861D0 (en) 1998-03-06 1998-04-29 Res Inst Medicine Chem Chemical compounds
EP1103300B1 (en) * 1998-07-03 2007-01-03 Chugai Seiyaku Kabushiki Kaisha Ultraviolet irradiation apparatus for photochemical reaction and method for preparing vitamin d derivative using the same
ATE462689T1 (de) * 1999-08-27 2010-04-15 Hiroaki Takayama Vitamin-d-derivate mit substituenten an der 2- alpha-position
JP4803939B2 (ja) 2000-04-19 2011-10-26 中外製薬株式会社 ビタミンｄ誘導体
CN100469764C (zh) 2000-06-15 2009-03-18 中外制药株式会社 维生素d衍生物
CN1449289A (zh) * 2000-08-30 2003-10-15 中外制药株式会社 Oct制剂
WO2012122451A2 (en) 2011-03-09 2012-09-13 Teva Pharmaceutical Industries Ltd. Polymorphs of maxacalcitol and process for the preparation of maxacalcitol
CN102796134B (zh) * 2012-08-31 2015-07-01 甘肃皓天化学科技有限公司 一种马沙骨化醇中间体的制备方法
CN103508999B (zh) 2013-10-12 2015-05-13 浙江海正药业股份有限公司 马沙骨化醇的合成中间体及其制备方法和用途
CN107286067A (zh) * 2016-04-05 2017-10-24 湖南华腾制药有限公司 一种马沙骨化醇的制备方法
WO2021107646A1 (ko) 2019-11-27 2021-06-03 연성정밀화학(주) 막사칼시톨의 제조방법 및 그를 위한 중간체

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61140560A (ja) * 1984-12-12 1986-06-27 Chugai Pharmaceut Co Ltd ２０−オキサ−２１−ノルビタミンｄ３誘導体
JPS61267550A (ja) * 1984-12-28 1986-11-27 Chugai Pharmaceut Co Ltd ９，１０−セコ−５，７，１０（１９）−プレグナトリエン誘導体
JP3050564B2 (ja) * 1989-12-15 2000-06-12 中外製薬株式会社 新規な２２―オキサビタミンｄ誘導体

Also Published As

Publication number Publication date
ES2107650T3 (es) 1997-12-01
SG78265A1 (en) 2001-02-20
TW222621B (xx) 1994-04-21
EP0619304A1 (en) 1994-10-12
WO1993012083A1 (en) 1993-06-24
KR940703807A (ko) 1994-12-12
DK0619304T3 (da) 1998-02-16
JP3493037B2 (ja) 2004-02-03
EP0619304A4 (en) 1995-03-29
DE69222183D1 (de) 1997-10-16
ATE157966T1 (de) 1997-09-15
JPH0672994A (ja) 1994-03-15
GR3025468T3 (en) 1998-02-27
DE69222183T2 (de) 1998-01-22
US5436401A (en) 1995-07-25
KR100247214B1 (ko) 2000-03-15
EP0619304B1 (en) 1997-09-10

Similar Documents

Publication Publication Date Title
HK1002729A1 (en) 22-oxacholecalciferol derivative and production thereof
AU4497993A (en) Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor
EP0370461A3 (en) Chalcone derivatives and process for producing the same
ZA200110520B (en) Pyrazole derivatives and process for producing the same, and pesticides containing the same as the active ingredient.
MX9606331A (es) Nuevos compuestos, procesos para la preparacion de los mismos y agentes antitumor.
HUT64944A (en) New aryl-glycide-amide derivatives and method for producing them
HUT47128A (en) Process for producing oxetanocins and pharmaceutical compositions comprising such compounds
DE69109514D1 (de) 4-(4-Alkoxyphenyl)-2-Butylaminderivate und deren Herstellungsverfahren.
HUT59378A (en) Process for producing urea derivatives and pharmaceutical compositions comprising such compounds
HU910748D0 (en) New substituted amine compounds and process for producing them
ES2032416T3 (es) Procedimiento para producir derivados de fluor de vitamina d3. (reserva del art. 167.2 cpe).
ES2144013T3 (es) Derivado de la vitamina d y procedimiento para su produccion.
GB9121943D0 (en) Organic compounds,processes for their production and their use
AU665980B2 (en) Process for producing prostaglandin E
NZ332245A (en) Substituted benzo-oxazolol carboxylic acid derivatives, process for their production and medicaments containing them
ES2122337T3 (es) Procedimiento para la produccion de semiesteres de acido sulfurico.
DK480389D0 (da) Antitumorstof, fremgangsmaade til dets fremstilling og anticancermiddel indeholdende stoffet
AU3630489A (en) Novel derivatives and processes for the production thereof
HK1047430A1 (en) Intermediates and process for producing fluorine-containing amino acid compound by using the same.
HU906407D0 (en) Process for producing new inozine- and guanozine derivatives and pharmaceutical compositions containing them as active components

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20061218